• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在印度,低质量的心血管护理是一个重要的冠状动脉风险因素。

Low quality cardiovascular care is important coronary risk factor in India.

作者信息

Gupta Rajeev, Khedar Raghubir S, Gaur Kiran, Xavier Denis

机构信息

Eternal Heart Care Centre & Research Institute, Mount Sinai New York Affiliate, Jaipur, India.

Eternal Heart Care Centre & Research Institute, Mount Sinai New York Affiliate, Jaipur, India.

出版信息

Indian Heart J. 2018 Dec;70 Suppl 3(Suppl 3):S419-S430. doi: 10.1016/j.ihj.2018.05.002. Epub 2018 May 17.

DOI:10.1016/j.ihj.2018.05.002
PMID:30595301
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6309144/
Abstract

Global Burden of Disease study has reported that cardiovascular and ischemic heart disease (IHD) mortality has increased by 34% in last 25 years in India. It has also been reported that despite having lower coronary risk factors compared to developed countries, incident cardiovascular mortality, cardiovascular events and case-fatality are greater in India. Reasons for the increasing trends and high mortality have not been studied. There is evidence that social determinants of IHD risk factors are widely prevalent and increasing. Epidemiological studies have reported low control rates of hypertension, hypercholesterolemia, diabetes and smoking/tobacco. Registries have reported greater mortality of acute coronary syndrome in India compared to developed countries. Secondary prevention therapies have significant gaps. Low quality cardiovascular care is an important risk factor in India. Package of interventions focusing on fiscal, intersectoral and public health measures, improvement of health services at community, primary and secondary healthcare levels and appropriate referral systems to specialized hospitals is urgently required.

摘要

全球疾病负担研究报告称,在过去25年里,印度心血管疾病和缺血性心脏病(IHD)死亡率上升了34%。另据报道,尽管与发达国家相比,印度的冠状动脉危险因素较低,但印度心血管疾病的新发死亡率、心血管事件和病死率更高。导致这些上升趋势和高死亡率的原因尚未得到研究。有证据表明,IHD危险因素的社会决定因素广泛存在且呈上升趋势。流行病学研究报告称,高血压、高胆固醇血症、糖尿病和吸烟/烟草的控制率较低。登记数据显示,与发达国家相比,印度急性冠状动脉综合征的死亡率更高。二级预防治疗存在重大差距。低质量的心血管护理是印度的一个重要危险因素。迫切需要一套侧重于财政、部门间和公共卫生措施的干预措施,改善社区、初级和二级医疗保健层面的卫生服务,以及建立适当的转诊至专科医院的系统。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6b8/6309144/5e2a37a7fb2e/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6b8/6309144/35a8ff8d1c8b/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6b8/6309144/5e33440024b0/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6b8/6309144/a053269cab3b/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6b8/6309144/e1a6f32b6111/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6b8/6309144/63009cbba733/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6b8/6309144/19d62fb97d97/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6b8/6309144/739b2b445738/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6b8/6309144/5e2a37a7fb2e/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6b8/6309144/35a8ff8d1c8b/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6b8/6309144/5e33440024b0/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6b8/6309144/a053269cab3b/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6b8/6309144/e1a6f32b6111/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6b8/6309144/63009cbba733/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6b8/6309144/19d62fb97d97/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6b8/6309144/739b2b445738/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6b8/6309144/5e2a37a7fb2e/gr8.jpg

相似文献

1
Low quality cardiovascular care is important coronary risk factor in India.在印度,低质量的心血管护理是一个重要的冠状动脉风险因素。
Indian Heart J. 2018 Dec;70 Suppl 3(Suppl 3):S419-S430. doi: 10.1016/j.ihj.2018.05.002. Epub 2018 May 17.
2
Coronary heart disease in low socioeconomic status subjects in India: "an evolving epidemic".印度社会经济地位较低人群中的冠心病:“一种不断演变的流行病”
Indian Heart J. 2009 Jul-Aug;61(4):358-67.
3
Premature coronary artery disease in India: coronary artery disease in the young (CADY) registry.印度的早发性冠状动脉疾病:青年冠状动脉疾病(CADY)登记处
Indian Heart J. 2017 Mar-Apr;69(2):211-216. doi: 10.1016/j.ihj.2016.09.009. Epub 2016 Nov 30.
4
Changing patterns in the prevalence and management of cardiovascular risk factors in India and their comparison with the rest of the world along with clinical outcomes at 5-year: An analysis of stable coronary artery disease patients from The Prospective Observational Longitudinal Registry of patients with stable coronary artery disease (CLARIFY) registry.印度心血管危险因素的患病率及管理模式的变化及其与世界其他地区的比较以及5年临床结局:对稳定型冠状动脉疾病患者前瞻性观察纵向登记研究(CLARIFY)登记处的稳定型冠状动脉疾病患者的分析
Indian Heart J. 2018 Dec;70 Suppl 3(Suppl 3):S36-S42. doi: 10.1016/j.ihj.2018.04.003. Epub 2018 Apr 24.
5
Challenges in management and prevention of ischemic heart disease in low socioeconomic status people in LLMICs.中低收入国家中社会经济地位较低人群的缺血性心脏病管理和预防面临的挑战。
BMC Med. 2019 Nov 26;17(1):209. doi: 10.1186/s12916-019-1454-y.
6
High prevalence of multiple coronary risk factors in Punjabi Bhatia community: Jaipur Heart Watch-3.旁遮普邦巴蒂亚社区多种冠状动脉危险因素的高患病率:斋浦尔心脏观察-3。
Indian Heart J. 2004 Nov-Dec;56(6):646-52.
7
Influence of coronary risk factors on coronary events in Japanese high-risk hypertensive patients. - Primary and secondary prevention of ischemic heart disease in a subanalysis of the Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) trial-.在日本高危高血压患者中,冠状动脉危险因素对冠状动脉事件的影响。——坎地沙坦降压生存评估在日本(CASE-J)试验中的亚分析:缺血性心脏病的一级和二级预防。
Circ J. 2011;75(10):2411-6. doi: 10.1253/circj.cj-10-1161. Epub 2011 Jul 20.
8
Cardiovascular risk factor control is insufficient in young patients with coronary artery disease.冠心病年轻患者的心血管危险因素控制不充分。
Vasc Health Risk Manag. 2016 May 25;12:219-27. doi: 10.2147/VHRM.S106436. eCollection 2016.
9
Tuberculosis结核病
10
Primary prevention and risk factor reduction in coronary heart disease mortality among working aged men and women in eastern Finland over 40 years: population based observational study.芬兰东部40多年来在职男女冠心病死亡率的一级预防和危险因素降低:基于人群的观察性研究。
BMJ. 2016 Mar 1;352:i721. doi: 10.1136/bmj.i721.

引用本文的文献

1
Influence of COVID-19 pandemic in India on coronary artery disease clinical presentation, angiography, interventions and in-hospital outcomes: a single centre prospective registry-based observational study.印度 COVID-19 大流行对冠心病临床表现、血管造影、介入治疗和住院结局的影响:一项基于单中心前瞻性登记的观察性研究。
BMJ Open. 2024 Mar 29;14(3):e078596. doi: 10.1136/bmjopen-2023-078596.
2
Low body mass index is associated with adverse cardiovascular outcomes following PCI in India: ACC-NCDR registry.低体重指数与印度经皮冠状动脉介入治疗后的不良心血管结局相关:美国心脏病学会-国家心血管数据注册库。
Int J Cardiol Cardiovasc Risk Prev. 2023 Dec 14;20:200230. doi: 10.1016/j.ijcrp.2023.200230. eCollection 2024 Mar.
3

本文引用的文献

1
25-Year trends in hypertension prevalence, awareness, treatment, and control in an Indian urban population: Jaipur Heart Watch.印度城市人口中高血压患病率、知晓率、治疗率和控制率的25年趋势:斋浦尔心脏观察
Indian Heart J. 2018 Nov-Dec;70(6):802-807. doi: 10.1016/j.ihj.2017.11.011. Epub 2017 Nov 13.
2
Effect of a Quality Improvement Intervention on Clinical Outcomes in Patients in India With Acute Myocardial Infarction: The ACS QUIK Randomized Clinical Trial.质量改进干预对印度急性心肌梗死患者临床结局的影响:急性冠状动脉综合征质量改进随机临床试验
JAMA. 2018 Feb 13;319(6):567-578. doi: 10.1001/jama.2017.21906.
3
Global action on the social determinants of health.
A Delphi Study to Prioritize Evidence-Based Strategies for Cardiovascular Disease Care in India.
一项关于确定印度心血管疾病护理循证策略优先级的德尔菲研究。
Glob Implement Res Appl. 2023 Jun 5:1-12. doi: 10.1007/s43477-023-00087-2.
4
Single-blind, randomized study comparing clinical equivalence of trulene and prolene polypropylene sutures in elective primary coronary artery bypass graft surgery.单盲、随机研究比较特伦伦和普罗伦聚丙烯缝线在择期冠状动脉旁路移植手术中的临床等效性。
J Cardiothorac Surg. 2022 Dec 16;17(1):315. doi: 10.1186/s13019-022-02095-z.
5
Revisiting secondary prevention in coronary heart disease.再探冠心病二级预防。
Indian Heart J. 2022 Nov-Dec;74(6):431-440. doi: 10.1016/j.ihj.2022.11.011. Epub 2022 Nov 29.
6
Association of health insurance status with coronary risk factors, coronary artery disease, interventions and outcomes in India.印度医疗保险状况与冠状动脉危险因素、冠状动脉疾病、干预措施及预后的关联
Int J Cardiol Cardiovasc Risk Prev. 2022 Aug 13;14:200146. doi: 10.1016/j.ijcrp.2022.200146. eCollection 2022 Sep.
7
Premature coronary artery disease, risk factors, clinical presentation, angiography and interventions: Hospital based registry.早发性冠状动脉疾病、危险因素、临床表现、血管造影和介入治疗:基于医院的注册研究。
Indian Heart J. 2022 Sep-Oct;74(5):391-397. doi: 10.1016/j.ihj.2022.08.003. Epub 2022 Aug 19.
8
Hypertension control in Kerala, India: A prescription-based study at primary and secondary level health care institutions.印度喀拉拉邦的高血压控制:初级和二级医疗机构的基于处方的研究。
Indian Heart J. 2022 Jul-Aug;74(4):296-301. doi: 10.1016/j.ihj.2022.05.005. Epub 2022 May 27.
9
Parity and later life risk for coronary heart disease among slum-dwelling women in Mysore, India.印度迈索尔贫民窟女性的均等化和晚年冠心病风险。
Indian Heart J. 2021 Sep-Oct;73(5):622-628. doi: 10.1016/j.ihj.2021.05.004. Epub 2021 Jun 2.
10
Cost Analysis of Health Examination Screening Program for Ischemic Heart Disease in Active-Duty Military Personnel in the Middle-Income Country.中低收入国家现役军人缺血性心脏病健康检查筛查计划的成本分析。
Front Public Health. 2021 Mar 4;9:634778. doi: 10.3389/fpubh.2021.634778. eCollection 2021.
针对健康的社会决定因素采取的全球行动。
BMJ Glob Health. 2017 Dec 1;3(Suppl 1):e000603. doi: 10.1136/bmjgh-2017-000603. eCollection 2018.
4
Universal health coverage and intersectoral action for health: key messages from Disease Control Priorities, 3rd edition.全民健康覆盖与卫生部门间行动:《疾病控制优先领域》第三版的主要信息。
Lancet. 2018 Mar 17;391(10125):1108-1120. doi: 10.1016/S0140-6736(17)32906-9. Epub 2017 Nov 25.
5
India-a tale of one country, but stories of many states.印度——一个国家的故事,众多邦的故事。
Lancet. 2017 Dec 2;390(10111):2413. doi: 10.1016/S0140-6736(17)32867-2. Epub 2017 Nov 14.
6
Nations within a nation: variations in epidemiological transition across the states of India, 1990-2016 in the Global Burden of Disease Study.一国之内的差异:1990-2016 年印度各邦的疾病流行转变的流行病学差异,全球疾病负担研究。
Lancet. 2017 Dec 2;390(10111):2437-2460. doi: 10.1016/S0140-6736(17)32804-0. Epub 2017 Nov 14.
7
Cardiovascular, respiratory, and related disorders: key messages from Disease Control Priorities, 3rd edition.心血管、呼吸及相关疾病:《疾病控制优先领域》第三版要点。
Lancet. 2018 Mar 24;391(10126):1224-1236. doi: 10.1016/S0140-6736(17)32471-6. Epub 2017 Nov 3.
8
The impact of systems-of-care on pharmacoinvasive management with streptokinase: The subgroup analysis of the TN-STEMI programme.护理系统对链激酶药物侵入性管理的影响:TN-STEMI项目的亚组分析。
Indian Heart J. 2017 Sep-Oct;69(5):573-579. doi: 10.1016/j.ihj.2017.07.006. Epub 2017 Jul 18.
9
Improved outcomes in patients with ST-elevation myocardial infarction during the last 20 years are related to implementation of evidence-based treatments: experiences from the SWEDEHEART registry 1995-2014.在过去的 20 年中,ST 段抬高型心肌梗死患者的治疗效果得到了改善,这与循证治疗的实施有关:来自 1995-2014 年 SWEDEHEART 注册研究的经验。
Eur Heart J. 2017 Nov 1;38(41):3056-3065. doi: 10.1093/eurheartj/ehx515.
10
The effect of physical activity on mortality and cardiovascular disease in 130 000 people from 17 high-income, middle-income, and low-income countries: the PURE study.体力活动对 17 个高收入、中等收入和低收入国家/地区 130000 人死亡率和心血管疾病的影响:PURE 研究。
Lancet. 2017 Dec 16;390(10113):2643-2654. doi: 10.1016/S0140-6736(17)31634-3. Epub 2017 Sep 21.